This study aimed to investigate the relationship between the expression of micro- This study suggested miR-181b/PIAS3/STAT3 axis as a novel target for colon cancer treatment.
| INTRODUCTION
Colon cancer is a leading cause of cancer death in the worldwide. 1, 2 About 1 million people suffer colon cancer every year, and it causes 0.6 million deaths annually around the world. 3 Despite advances in surgical treatment, the 5-year overall survival rate of patients with metastatic colon cancer is only 5%-10%. 4 Therefore, it is necessary to investigate the molecular mechanisms underlying colon cancer development so as to contrive novel strategies for colon cancer treatment.
Cancer cells rewire their metabolism to promote cancer progression. The common feature of this altered metabolism is that cancer cells preferentially produce energy by a high rate of glycolysis followed by lactic acid fermentation in the cytosol, 5, 6 rather than by a comparatively low rate of glycolysis followed by oxidation of pyruvate in mitochondria as in most normal cells. 7 This phenomenon is referred as the Warburg effect, which has been documented for over 90 years. The Warburg effect is considered as one of the most fundamental metabolic alteration associated with malignant transformation; however, it remains unclear how the Warburg effect is regulated during tumour progression.
MicroRNAs (miRNAs or miR) are a class of small non-coding RNAs that regulate gene expression at the post-transcriptional and translational levels through binding to the 3′untranslated region (3′UTR) of target mRNAs. The roles of miRNAs in cancer progression have been well-documented and several miRNAs such as miR-223, miR-133, and miR-200 family have been implicated in the regulation of aerobic glycolysis in cancer. 8 MiR-181b is an important miRNA which is correlated with tumorigenesis. 9 MiR-181b has been shown to exert its effect on cancer by regulating cell proliferation, apoptosis, invasion and migration. 10, 11 Recently, the role of miR-181b in regulating aerobic glycolysis in cancer has attracted much concern. 12, 13 Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that mediates cellular responses to various cytokines and growth factors. Recently, some studies reveal that STAT3 acts as a master regulator of aerobic glycolysis. [14] [15] [16] regulates the Warburg effect via promoting aerobic glycolysis and downregulating mitochondrial activity. 16 Protein inhibitor of activated STAT 3 (PIAS3) is a specific inhibitor of STAT3. It has been
shown that ectopic expression of PIAS3 in cancer cells can suppress the transcriptional activity of STAT3 and inhibit tumour growth. 17, 18 In the present study, we explored the relationship between miR181b (miR-181b-5p), PIAS3 and STAT3, and investigated the function of miR-181b/PIAS3/STAT3 axis on the Warburg effect and xenograft tumour growth of colon cancer. Moreover, a miR-181b-STAT3 positive feedback loop that contributed to the Warburg effect in colon cancer cells was demonstrated as well.
| MATERIALS AND METHODS

| Cell culture and transfection
HCT 116, HT-29, and HEK-293T cells were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). Cells were cultured in RPMI 1640 medium (Gibco Life Technologies, Carlsbad, CA) containing 10% foetal bovine serum (FBS; Gibco Life Technologies) and maintained at 37°C in a humidified atmosphere with 5% CO 2 . The miR-181b mimic (miR-181b)/inhibitor (as-miR181b), miR-181b negative control (miR NC), as-miR NC, STAT3 siRNAs (siRs), PIAS3 siRs, scramble (Scr) siR, and pFlag-PIAS3 plasmid were designed and synthesized by Gene Pharma (Shanghai, China).
The sequences of miRNAs and siRs were shown in Table 1 . Cell transfection (plasmid 4.0 μg, RNA 100 pmol/L) was performed using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions.
| Xenograft experiments
This study was approved by the Ethics Committee of Nanjing Medical University. The BALB/C nude mice (female, 4 weeks, 18-22 g)
were purchased from the Laboratory Animal Center of Nanjing Medical University. The mice were randomly distributed to 6 groups: asmiR negative control (NC) group, as-miR-181b group, pFlag group, pFlag-PIAS3 group, as-miR-181b + Scramble (Scr) siR group, and asmiR-181b + PIAS3 siR group. The protocol referred to a previous publication. 19 In brief, HCT 116 cells (5 × as-miR-181b 5′-ACCCACCGACAGCAAUGAAUGUU-3′
as-miR NC 5′-CAGUACUUUUGUGUAGUACAA-3′
| 5041 5 days for 5 weeks, and tumour volume was calculated using the 
| Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
After transfection for 48 hours, total RNA was isolated from cells using the TRIzol Reagent (Invitrogen) according to the manufacturer's instructions. 1 μg of total RNA was transcribed to cDNA using the M-MLV Reverse Transcriptase (Invitrogen). RT-qPCR was performed using SYBR Premix Ex Taq Real-Time kit (Takara, Japan) on a StepOne Real-Time PCR System (Applied Biosystems, Foster City, CA).
The primers used were: miR-181b, 5′-GCGGATCATTCATTGC TGTCG-3′(forward), 5′-GTGCAGGGTCCGAGGT-3′(reverse); PIAS3,
GT-3′(reverse). β-actin and U6 were used as the control.
| Western blot
After transfection for 24 hours, cells were lyzed in lysis buffer 
| Statistical analysis
Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Tukey's post hoc test with SPSS software (version 17.0; Chicago, IL). The data were obtained from at least three independent experiments and presented as the mean ± standard deviation (SD). P < 0.05 was considered to indicate a statistically significant result.
| RESULTS
| miR-181b directly targets PIAS3
We used Targetscan, Pictar, and miRanda to search for the putative transcription binding sites of miR-181b and PIAS3 3′UTR, and the predicted sites were shown in Figure 1A . miR-181b mimic or inhibitor was transfected into the cells to overexpress or knockdown miR-181b expression, respectively. As demonstrated in Figure 1B 
| PIAS3 reverses the effect of miR-181b on the Warburg effect in colon cancer cells
To reveal the effect of miR-181b on aerobic glycolysis in colon cancer cells, miR-181b inhibitor was transfected into the HCT 116 cells to knockdown miR-181b, and then glucose and lactic acid were detected using the commercial kits. As shown in Figure 2A , knockdown of miR-181b significantly decreased the glucose consumption Further, we found the glucose consumption and lactic acid production were significantly inhibited in the PIAS3-overexpressing cells ( Figure 2C ).
To investigate whether PIAS3 mediated the effect of miR181b on aerobic glycolysis in colon cancer cells, we synthesized three PIAS3 siRs to knockdown PIAS3 and found that PIAS3 siR-3 was the most efficient siRNA ( Figure 2D ). Subsequently, PIAS3
siR-3/Scr siRNA were cotransfected with as-miR-181b into the HCT 116 cells, and the glucose consumption and lactic acid production were determined. As shown in Figure 2E , compared with the control, HCT 116 cells with suppressed expression of PIAS3
showed significantly increased glucose consumption and lactic acid production.
| PIAS3 reverses the effect of miR-181b on xenograft tumour growth
To investigate the effect of miR-181b on xenograft tumour growth, HCT 116 cells transfected with as-miR-181b or as-miR NC were injected into the nude mice, and the tumour growth was monitored and measured. It was observed that the tumour volume was significantly decreased in miR-181b-knockdown tumours compared with that of the control tumours (Figure 3A) .As shown in Figure 3B , the tumour volumes of xenograft tumours with a high level of PIAS3 expression were decreased compared with that of the control tumours. Furthermore, we found the tumour volume in the as-miR-181b + PIAS3 siR group F I G U R E 3 siPIAS3 Reverses the Effect of miR-181b on Xenograft Tumour Growth. A, miR-181b knockdown inhibits xenograft tumour growth. B, PIAS3 overexpression inhibits xenograft tumour growth. C, siPIAS3 reverses the effect of miR-181b on xenograft tumour growth was larger than that in the as-miR-181b + Scr siR group (Figure 3C ).
| PIAS3 reverses the effect of miR-181b on the phosphorylation of STAT3
The miR-181b and miR NC were transfected into the HCT 116 cells.
The as-miR-181b and as-miR NC were transfected into the HT-29 cells. Western blot was performed to examine the protein expression of STAT3 and p-STAT3. As shown in Figure 4A , transfection with the miR-181b significantly increased the relative protein level of p-STAT3. Figure S1 showed that transfection with the as-miR-181b
significantly decreased the protein level of p-STAT3. However, the promotive effect of miR-181b on the phosphorylation of STAT3 was reversed by transfection with pFlag-PIAS3 ( Figure 4B ).
| PIAS3 overexpression suppresses p-STAT3 and miR-181b expression
The pFlag-PIAS3 was transfected into the HCT 116 and HT-29 cells to overexpress PIAS3. Subsequently, the protein expression of STAT3 and p-STAT3 was examined by western blot, and the miR181b expression was detected by RT-qPCR. We found PIAS3 overexpression could suppress the p-STAT3 and miR-181b expression ( Figures 5 and S2 ).
| STAT3 suppression down-regulates miR-181b and up-regulates PIAS3
To 
| DISCUSSION
In this study, we used bioinformatics softwares (Targetscan, http:// www.targetscan.org; Pictar, http://pictar.mdc-berlin.de/; and miRanda, http://www.microrna.org/microrna/home.do) to identify the potential targets of miR-181b, and found PIAS3 was a predicted one. Through luciferase reporter assay, we found miR-181b mimic was able to suppress luciferase activity encoded by a reporter gene fused to the PIAS3 3′UTR. In addition, the mRNA and protein levels of PIAS3 were down-regulated by miR-181b mimic, and up-regulated by miR-181b inhibitor. These results for the first time validated miR181b as a direct regulator of PIAS3.
Previous studies had revealed that miR-181b expression was altered in numerous types of cancer, and the expression pattern was cell specific. Down-regulation of miR-181b had been detected in lung cancer and prostate cancer, while up-regulation of miR-181b had been demonstrated in acute myeloid leucemia and oral carcinoma. [21] [22] [23] [24] Previous studies conducted in patients with colon cancer reported that miR-181b was overexpressed in tumour samples compared with the normal samples, [25] [26] [27] [28] [29] and especially there was a positive correlation between high expression of miR-181b and poor survival of patients with stage III colon cancer. 27, 30 The Warburg effect is a well-known feature in cancer-specific metabolism, and it has been extensively studied over the past 10 years. Several strategies and small molecules which are capable of inhibiting glycolytic metabolism of cancer cells have promising anticancer activity in vitro and in vivo. 31, 32 In the present study, we investigated the role of miR- Importantly, this study provided a new evidence on the role of miR-181b-mediated positive feedback loops in STAT3 activation. We demonstrated that miR-181b directly bound to the PIAS3 3′UTR and inhibited the expression of PIAS3, and PIAS3 suppression contributed to the activation of STAT3. The proline, isoleucine, asparagine, isoleucine, threonine (PINIT) motif is one of several conserved domains of the PIAS family. 37, 38 The PINIT domain allows nuclear translocation of PIAS3 37, 38 and it is known to promote STAT3-PIAS3
interaction. 39 A short stretch of 50 amino acids in the PINIT domain of PIAS3 (PIAS3 82-132 ) can directly interact with STAT3 and downregulate STAT3-dependent transcriptional activity. 37, 38 The (His)(7) - cytokines activating STAT3. 42 In colon cancer cells, to date, there is no clear answer to whether JAK can affect miR-181b expression and whether it is induced by STAT3 activator, which needs to be further studied. We will explore this issue in next study. | 5047
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